LAM
ABBV icon

LECAP Asset Management’s AbbVie ABBV Stock Holding History

LECAP Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,627
Closed -$488K – 268
2025
Q2 		$488K Buy
+2,627
New +$488K 0.17% 207
2024
Q4 		– Sell
-6,008
Closed -$1.19M – 280
2024
Q3 		$1.19M Buy
+6,008
New +$1.12M 0.26% 148
2024
Q1 		– Sell
-5,059
Closed -$784K – 283
2023
Q4 		$784K Buy
+5,059
New +$738K 0.29% 136

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LECAP Asset Management's ABBV Position: Q3 2025 in Review

LECAP Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 2,627 shares — an estimated $488K sold.

LECAP Asset Management first reported a position in ABBV in Q4 2023 and held it in 3 quarters. The position peaked at $1.19M in Q3 2024. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • LECAP Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • LECAP Asset Management sold 2,627 AbbVie shares in Q3 2025, an estimated $488K.
  • LECAP Asset Management first reported a position in AbbVie in Q4 2023 and held it in 3 quarters.
  • LECAP Asset Management's AbbVie position peaked at $1.19M in Q3 2024.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on LECAP Asset Management's 13F filing for Q3 2025, filed 23 Oct 2025.